Big Foot Forward With AI To Treat Insulin Dependent Diabetics
Background of Diabetic Market in the US According to a 2020 Center for Disease Control (“CDC”), the United States has approximately 34 million people with…
Carl Aridas
FDA Approves Marketing of AI/ML Device To Find Colon Cancer
The Impact of Colon Cancer According to the National Institutes of Health (NIH), colon cancer is the third-leading type of cancer death in the United…
Overview of FDA’s AI/ML-Based Software as a Medical Device Action Plan
In a landmark effort to both guide and spur artificial intelligence (AI) and machine learning (ML) development in the medical field, the US Food and…
Tools for Reporting with the FR 2052a Complex Institution Liquidity Monitoring Report
Previously, I outlined the data that can be reported with the FR 2052a Complex Institution Liquidity Monitoring Report. My next blog will review the tools…
Data to Be Reported with the FR 2052a Complex Institution Liquidity Monitoring Report
In my last blog I discussed the consolidations required for success with the FR 2052a Complex Institution Liquidity Monitoring Report. My next blog will outline…
Consolidating Institutions with the FR 2052a Complex Institution Liquidity Monitoring Report
In my last blog I outlined the recent changes to the FR 2052a Complex Institution Liquidity Monitoring Report. Now I want to discuss the consolidations…
Recent Changes to the FR 2052a Complex Institution Liquidity Monitoring Report
Previously, I discussed the history FR 2052a Complex Institution Liquidity Monitoring Report. My next blog will outline the recent changes to the report. As allowed…
[Guide] Breaking Down the FR 2052a Complex Institution Liquidity Monitoring Report
The financial crisis of 2008 and 2009 highlighted the need for timely data to identify and monitor liquidity risks at individual firms, as well as…